A Phase 1 Study to Evaluate the Potential Drug Interactions Between ALXN2080 and Rosuvastatin and Metformin in Healthy Adult Participants
Latest Information Update: 13 Mar 2024
At a glance
- Drugs ALXN-2080 (Primary) ; Metformin; Rosuvastatin
- Indications Unspecified
- Focus Pharmacokinetics
- Sponsors Alexion AstraZeneca Rare Disease
- 05 Mar 2024 Status changed from not yet recruiting to completed.
- 11 Dec 2023 New trial record